Session Information

Filter Results:

Show Only CME Accredited Sessions

  • +

    JCSE 01 - Joint IASLC/CSCO/CAALC Session: Immunotherapy for Management of Lung Cancer: Ongoing Research from East and West

    • 07:30 - 11:30
    • 10/15/2017
    • Location: F203 (Annex Hall)
    • Type: Joint Session IASLC/CSCO/CAALC
    • Track: Immunology and Immunotherapy
    • +

      JCSE 01.18 - Uncommon Mutation Types of EGFR and Response to EGFR Tyrosine Kinase Inhibitors in Chinese Non-Small Cell Lung Cancer Patients

      11:30 - 11:30  |  Presenter: Yun Fan  |  Author(s): K. Chen, X. Yu, H. Wang, Z. Huang, Y. Xu, L. Gong

      • Abstract

      Loading...

  • +

    MA 03 - Chemotherapy

    • 11:00 - 12:30
    • 10/16/2017
    • Location: Room 502
    • Type: Mini Oral
    • Track: Advanced NSCLC
  • +

    OA 06 - Global Tobacco Control and Epidemiology I

    • 15:45 - 17:30
    • 10/16/2017
    • Location: Room 511 + 512
    • Type: Oral
    • Track: Epidemiology/Primary Prevention/Tobacco Control and Cessation
  • +

    P2.01 - Advanced NSCLC

    • 09:00 - 16:00
    • 10/17/2017
    • Location: Exhibit Hall (Hall B + C)
    • Type: Poster Session with Presenters Present
    • Track: Advanced NSCLC
    • +

      P2.01-057 - Activity of Pemetrexed on Wild-Type and Unknown Status EGFR Genes with Brain Metastases from Non-Small Cell Lung Cancer

      09:00 - 09:00  |  Presenter: Yun Fan  |  Author(s): X. Yu

      • Abstract

      Loading...

  • +

    P2.03 - Chemotherapy/Targeted Therapy

    • 09:30 - 16:00
    • 10/17/2017
    • Location: Exhibit Hall (Hall B + C)
    • Type: Poster Session with Presenters Present
    • Track: Chemotherapy/Targeted Therapy
    • +

      P2.03-013 - Uncommon Mutation Types of EGFR and Response to EGFR Tyrosine Kinase Inhibitors in Chinese Non-Small Cell Lung Cancer Patients

      09:30 - 09:30  |  Presenter: Yun Fan  |  Author(s): K. Chen, X. Yu, H. Wang, Z. Huang, Y. Xu, L. Gong

      • Abstract

      Loading...

  • +

    P2.04 - Clinical Design, Statistics and Clinical Trials

    • 09:30 - 16:00
    • 10/17/2017
    • Location: Exhibit Hall (Hall B + C)
    • Type: Poster Session with Presenters Present
    • Track: Clinical Design, Statistics and Clinical Trials
  • +

    P2.07 - Immunology and Immunotherapy

    • 09:30 - 16:00
    • 10/17/2017
    • Location: Exhibit Hall (Hall B + C)
    • Type: Poster Session with Presenters Present
    • Track: Immunology and Immunotherapy
    • +

      P2.07-057 - Anti-PD-1/PD-L1 Antibodies Combine with Chemotherapy or CTLA4 Antibodies for First-Line Treatment of Advanced Lung Cancer

      09:30 - 09:30  |  Presenter: Yun Fan  |  Author(s): X. Xu

      • Abstract

      Loading...

  • +

    P3.01 - Advanced NSCLC

    • 09:30 - 16:00
    • 10/18/2017
    • Location: Exhibit Hall (Hall B + C)
    • Type: Poster Session with Presenters Present
    • Track: Advanced NSCLC
    • +

      P3.01-069 - Three Treatments for EGFR-Mutant Non-Small-Cell Lung Cancer with Brain Metastases

      09:30 - 09:30  |  Presenter: Yun Fan  |  Author(s): X. Yu, H. Wang

      • Abstract

      Loading...

  • +

    P3.03 - Chemotherapy/Targeted Therapy

    • 09:30 - 16:00
    • 10/18/2017
    • Location: Exhibit Hall (Hall B + C)
    • Type: Poster Session with Presenters Present
    • Track: Chemotherapy/Targeted Therapy
    • +

      P3.03-030 - TP53 Alteration, a Potential Primary Cause of Early Progression in EGFR-Mutated NSCLC Patients Treated with First-Line TKIs

      09:30 - 09:30  |  Presenter: Yun Fan  |  Author(s): Y. Xu, Z. Huang, H. Lu

      • Abstract

      Loading...

    • +

      P3.03-031 - Response to Crizotinib Can Occur in C-MET Overexpression NSCLC Independent of MET exon14 Alterations After First-Line EGFR-TKI Resistance

      09:30 - 09:30  |  Presenter: Yun Fan  |  Author(s): Y. Xu, Z. Huang

      • Abstract

      Loading...